MD Anderson and Resilience Launch Joint Venture to Accelerate Development and Manufacturing of Innovative Cell Therapies for Cancer
June 03, 2022
June 03, 2022
HOUSTON, Texas, June 3 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release on June 2, 2022:
The University of Texas MD Anderson Cancer Center and National Resilience, Inc., today announced the launch of a joint venture, the Cell Therapy Manufacturing Center, to accelerate the development and manufacturing of innovative cell therapies for patients with cancer. Uniting the strengths of Resilience and MD Anderson, the joint venture wil . . .
The University of Texas MD Anderson Cancer Center and National Resilience, Inc., today announced the launch of a joint venture, the Cell Therapy Manufacturing Center, to accelerate the development and manufacturing of innovative cell therapies for patients with cancer. Uniting the strengths of Resilience and MD Anderson, the joint venture wil . . .